West Pharmaceutical Services Inc (WST)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$261.03

Buy

$273.66

arrow-down$-4.98 (-1.83%)

Prices updated at 12 Dec 2025, 22:59 EST

Prices minimum 15 mins delay

Prices in USD

West Pharmaceutical Services Inc develops, manufactures and sells packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, and prefillable syringe components.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Mr. Eric Mark Green

CEO

Mr. Eric Mark Green

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

10,600

Head office

530 Herman O. West Drive

Exton

United States

19341-1147

+1 610 594-2900

John.Sweeney@westpharma.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Robert W. McMahon Senior Vice President and Chief Financial Officer	-
Ms. Kimberly Banks MacKay Senior Vice President, General Counsel and Corporate Secretary	0.48m
Mr. Shane Campbell Senior Vice President and Chief Proprietary Segment Officer	-
Ms. Deborah L.V. Keller Independent Director	0.12m
Mr. Douglas A. Michels Independent Director	0.10m
Mr. Paolo Pucci Lead Independent Director	0.14m
Mr. Robert F. Friel Independent Director	0.12m
Mr. Thomas W. Hofmann Independent Director	0.13m
Ms. Janet Brutschea Haugen Independent Director	0.01m
Mr. Mark A. Buthman Independent Director	0.12m
Dr. Myla P. Lai-Goldman,M.D. Independent Director	0.12m
Mr. Eric Mark Green Chief Executive Officer, President and Chairman of the Board	1.17m
Dr. William F. Feehery, PhD Independent Director	0.10m
Ms. Annette F. Favorite Senior Vice President and Chief Human Resources Officer	0.45m
Ms. Molly E. Joseph Independent Director	0.10m
Mr. Chad R. Winters Vice President, Finance and Chief Accounting Officer	-
Dr. Stephen H. Lockhart, PhD Independent Director	0.10m
Mr. Quintin J. Lai Vice President, Strategy and Investor Relations	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	9,316,804
BlackRock Inc	6,455,861
State Street Corp	3,207,911
Bank of New York Mellon Corp	2,904,709
Artisan Partners Limited Partnership	2,770,920

Director dealings

Date chevron-l-regular chevron-r-regular	Action
16 Dec 2024	-
29 Oct 2024	-
29 Oct 2024	-
29 Oct 2024	-
06 Aug 2024	-
06 Aug 2024	-
06 Aug 2024	-
06 Aug 2024	-
06 Aug 2024	-
12 Jun 2024	-
10 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.